Johnson & Johnson Invests $1 Billion in Firefly Bio to Boost KRAS Inhibitor Portfolio
In a significant move to enhance its oncology pipeline, Johnson & Johnson has announced the acquisition of Firefly Bio for $1 billion, focusing on KRAS inhibitors.
10 articles tagged with "biotechnology"
In a significant move to enhance its oncology pipeline, Johnson & Johnson has announced the acquisition of Firefly Bio for $1 billion, focusing on KRAS inhibitors.
Recent advancements in AI technology have led to the development of compounds that target specific cell types, potentially transforming drug discovery processes.
A new partnership between Alnylam and Inceptive Nucleics, valued at up to $2 billion, aims to leverage AI foundation models to enhance RNA interference therapeutics over the next three years.
A novel method utilizing laser technology has been developed to construct protein networks resembling those found in living cells, potentially advancing biological studies.
Researchers at the University of Hong Kong have developed an innovative RNA-based technique that may significantly impact the treatment of neurodegenerative diseases.
Researchers from the University of Toronto have created a suite of low-cost, portable biomanufacturing tools aimed at improving access in remote laboratories.
Research indicates that by transferring nitrogen-fixing genes into new bacterial strains, major crops may be able to draw nitrogen from the atmosphere, potentially reducing fertilizer costs.
Recent research focuses on genetically modifying cyanobacteria to enhance the production of sulfated polysaccharides, which have various industrial applications.